A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
UTC Therapeutics Inc.
Xencor, Inc.
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)